Eli Lilly and Company
Patents, Design & Utilities
Last updated:
List of all Eli Lilly and Company patents 385 in total
| Status | Patent |
|---|---|
Application | Utility: Treatment of Genital Psoriasis Filling date: 18 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: PROTEIN TYROSINE-TYROSINE ANALOGS AND METHODS OF USING THE SAME Filling date: 18 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: ANTI-PACAP ANTIBODY Filling date: 18 Sep 2025 Issue date: 30 Apr 2020 |
Application | Utility: Treatment of Primary Biliary Cholangitis and Primary Sclerosing Cholangitis with Baricitinib Filling date: 18 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: [1,2,4]TRIAZOLO[4,3-A]PYRAZIN-6(5H)-ONE DERIVATIVES Filling date: 18 Sep 2025 Issue date: 23 Apr 2020 |
Grant | Utility: Accelerated testing method of silicone drainage in syringes Filling date: 18 Sep 2025 Issue date: 21 Apr 2020 |
Application | Utility: KRAS G12C INHIBITORS Filling date: 18 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: DOSE DETECTION SYSTEM MODULE FOR MEDICATION DELIVERY DEVICE Filling date: 18 Sep 2025 Issue date: 16 Apr 2020 |
Grant | Design: Container assembly Filling date: 18 Sep 2025 Issue date: 14 Apr 2020 |
Grant | Utility: Anti-TrkA antibody Filling date: 18 Sep 2025 Issue date: 14 Apr 2020 |
Grant | Utility: Dopamine D1 receptor positive allosteric modulators Filling date: 18 Sep 2025 Issue date: 7 Apr 2020 |
Grant | Utility: BTLA agonist antibodies and uses thereof Filling date: 18 Sep 2025 Issue date: 31 Mar 2020 |
Grant | Utility: Compounds useful for inhibiting ROR-gamma-t Filling date: 18 Sep 2025 Issue date: 31 Mar 2020 |
Application | Utility: 6-Fluoro-2-Methylbenzo[d]thiazol-5-yl Compounds Filling date: 18 Sep 2025 Issue date: 26 Mar 2020 |
Grant | Utility: Acylated insulin compound Filling date: 18 Sep 2025 Issue date: 24 Mar 2020 |
Application | Utility: CD200R AGONIST ANTIBODIES AND USES THEREOF Filling date: 18 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: RAPID-ACTING INSULIN COMPOSITIONS Filling date: 18 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: 7-PHENYLETHYLAMINO-4H-PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AS MUTANT IDH1 AND IDH2 INHIBITORS Filling date: 18 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: MEDICATION DELIVERY DEVICE WITH SENSING SYSTEM Filling date: 18 Sep 2025 Issue date: 12 Mar 2020 |
Grant | Utility: Anti-Dkk-1-anti-RANKL bispecific antibody compounds Filling date: 18 Sep 2025 Issue date: 10 Mar 2020 |
Application | Utility: 2,6-DIAMINO PYRIDINE COMPOUNDS Filling date: 18 Sep 2025 Issue date: 5 Mar 2020 |
Grant | Utility: Anti-CGRP/anti-IL-23 bispecific antibodies and uses thereof Filling date: 18 Sep 2025 Issue date: 3 Mar 2020 |
Application | Utility: ISOQUINOLIN AND NAPHTHYDRIN COMPOUNDS Filling date: 18 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: MET ANTIBODY DRUG CONJUGATES Filling date: 18 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: THERAPY FOR METATASTIC COLORECTAL CANCER USING ANTI-VEGFR-2 and ANTI-VEGF-D ANTIBODIES Filling date: 18 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: ENDOCRINE THERAPY AND ABEMACICLIB COMBINATION FOR THE ADJUVANT TREATMENT OF NODE-POSITIVE, EARLY STAGE, HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE BREAST CANCER Filling date: 18 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: TREATMENT OF CANCER WITH EXON 14 SKIPPING MUTATION(S) OR EXON 14 SKIPPING PHENOTYPE Filling date: 18 Sep 2025 Issue date: 20 Feb 2020 |
Grant | Utility: Methods for producing Fabs and bi-specific antibodies Filling date: 18 Sep 2025 Issue date: 18 Feb 2020 |
Application | Utility: ANTI-IL-33 ANTIBODIES AND USES THEREOF Filling date: 18 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: COMPOUNDS USEFUL FOR INHIBITING ROR-GAMMA-T Filling date: 18 Sep 2025 Issue date: 13 Feb 2020 |
Grant | Utility: Targeted treatment of leiomyosarcoma Filling date: 18 Sep 2025 Issue date: 11 Feb 2020 |
Application | Utility: PROCESSES AND DEVICES FOR DELIVERY OF FLUID BY CHEMICAL REACTION Filling date: 18 Sep 2025 Issue date: 30 Jan 2020 |
Application | Utility: CONDENSED THIOPHENE DERIVATIVES USEFUL AS NAPI-IIB INHIBITORS Filling date: 18 Sep 2025 Issue date: 30 Jan 2020 |
Application | Utility: GIP/GLP1 CO-AGONIST COMPOUNDS Filling date: 18 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: METHODS OF USING A GIP/GLP1 CO-AGONIST FOR THERAPY Filling date: 18 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: DOSE DETECTION AND DRUG IDENTIFICATION FOR A MEDICATION DELIVERY DEVICE Filling date: 18 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: ANTI-TIM-3 ANTIBODIES FOR COMBINATION WITH ANTI-PD-L1 ANTIBODIES Filling date: 18 Sep 2025 Issue date: 23 Jan 2020 |
Grant | Utility: Sensing system for medication delivery device Filling date: 18 Sep 2025 Issue date: 21 Jan 2020 |
Application | Utility: (E)-1-(4-(DIMETHYLAMINO)BUT-2-ENOYL)PYRROLIDIN-3-YL 4-((3-ISOPROPYL-5-METHYLPYRAZOLO[1,5-A]PYRIMIDIN-7-YL)AMINO)PIPERIDINE-1-- CARBOXYLATE FOR INHIBITING CDK7 Filling date: 18 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: SELECTIVE ESTROGEN RECEPTOR DEGRADERS Filling date: 18 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: ACCELERATED TESTING METHOD OF SILICONE DRAINAGE IN SYRINGES Filling date: 18 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: COMPOUNDS USEFUL FOR INHIBITING ROR-GAMMA-T Filling date: 18 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: AZETIDINYLOXYPHENYLPYRROLIDINE COMPOUNDS Filling date: 18 Sep 2025 Issue date: 2 Jan 2020 |
Grant | Utility: Inhibiting the transient receptor potential A1 ion channel Filling date: 18 Sep 2025 Issue date: 31 Dec 2019 |
Grant | Utility: Anti-PACAP antibody Filling date: 18 Sep 2025 Issue date: 31 Dec 2019 |
Application | Utility: GIP/GLP1 AGONIST COMPOSITIONS Filling date: 18 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF Filling date: 18 Sep 2025 Issue date: 19 Dec 2019 |
Grant | Utility: Anti-IL-33 antibodies and uses thereof for disease treatment Filling date: 18 Sep 2025 Issue date: 10 Dec 2019 |
Application | Utility: COMBINATION THERAPY OF BACE-1 INHIBITOR AND ANTI-N3PGLU ABETA ANTIBODY Filling date: 18 Sep 2025 Issue date: 5 Dec 2019 |
Grant | Utility: PD-1 agonist antibodies and uses thereof Filling date: 18 Sep 2025 Issue date: 3 Dec 2019 |
Showing 300 to 350 of 385 patents.